Bumper Offer - Urjas oil Just @ Rs. 1
Gabawin NT 75/10 Tablet is a prescription medicine that is available as a Tablet. The alternative uses of Gabawin NT 75/10 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Gabawin NT 75/10 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Gabawin NT 75/10 Tablet as well, which are listed below. Usually, these side effects of Gabawin NT 75/10 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Gabawin NT 75/10 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Gabawin NT 75/10 Tablet related warnings talks about Gabawin NT 75/10 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Heart Disease, Coronary Artery Disease (CAD) must refrain from the use of Gabawin NT 75/10 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Gabawin NT 75/10 Tablet are listed in the contraindications section below.
Besides this, Gabawin NT 75/10 Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Gabawin NT 75/10 Tablet is considered not safe while driving, and is not addictive.
Gabawin NT 75/10 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Gabawin NT 75/10 Tablet is used -
Moderate
Mild
Is the use of Gabawin NT 75/10 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Gabawin NT. It is best to stop taking Gabawin NT immediately and inform your doctor if you notice any discomfort.
Is the use of Gabawin NT 75/10 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Gabawin NT. So it is adviced to consult the doctor before using it.
What is the effect of Gabawin NT 75/10 Tablet on the Kidneys?
There are no side effects of Gabawin NT on the kidneys.
What is the effect of Gabawin NT 75/10 Tablet on the Liver?
Side effects of Gabawin NT rarely affect the liver.
What is the effect of Gabawin NT 75/10 Tablet on the Heart?
Gabawin NT may have mild side effects on the heart. Most people will never see any effect on the heart.
Gabawin NT 75/10 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gabawin NT 75/10 Tablet unless your doctor advises you to do so -
Is this Gabawin NT 75/10 Tablet habit forming or addictive?
No, you will not get addicted to Gabawin NT 75/10 Tablet.
Interaction between Food and Gabawin NT 75/10 Tablet
Taking Gabawin NT 75/10 Tablet with food does not cause any problems.
Interaction between Alcohol and Gabawin NT 75/10 Tablet
Consult your doctor before consuming alcohol while taking Gabawin NT 75/10 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
